Whitcomb & Hess’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $323K | Sell |
1,741
-3
| -0.2% | -$557 | 0.09% | 44 |
|
|
2025
Q1 | $365K | Sell |
1,744
-7
| -0.4% | -$1.47K | 0.11% | 40 |
|
|
2024
Q4 | $311K | Sell |
1,751
-25
| -1% | -$4.44K | 0.1% | 42 |
|
|
2024
Q3 | $351K | Sell |
1,776
-61
| -3% | -$12K | 0.1% | 40 |
|
|
2024
Q2 | $315K | Sell |
1,837
-63
| -3% | -$10.8K | 0.1% | 41 |
|
|
2024
Q1 | $346K | Sell |
1,900
-582
| -23% | -$106K | 0.11% | 42 |
|
|
2023
Q4 | $385K | Buy |
2,482
+139
| +6% | +$21.5K | 0.13% | 35 |
|
|
2023
Q3 | $349K | Buy |
2,343
+7
| +0.3% | +$1.04K | 0.13% | 33 |
|
|
2023
Q2 | $315K | Buy |
2,336
+7
| +0.3% | +$943 | 0.11% | 33 |
|
|
2023
Q1 | $371K | Buy |
2,329
+389
| +20% | +$62K | 0.14% | 31 |
|
|
2022
Q4 | $314K | Buy |
1,940
+93
| +5% | +$15K | 0.13% | 32 |
|
|
2022
Q3 | $248K | Sell |
1,847
-12
| -0.6% | -$1.61K | 0.11% | 30 |
|
|
2022
Q2 | $285K | Buy |
1,859
+5
| +0.3% | +$767 | 0.12% | 29 |
|
|
2022
Q1 | $300K | Buy |
1,854
+1
| +0.1% | +$162 | 0.12% | 26 |
|
|
2021
Q4 | $264K | Buy |
+1,853
| New | +$264K | 0.1% | 30 |
|